Quick Answer
NOVAVAX INC reported Operating Income Loss of $452.80 million for the year ending 2025.
- NOVAVAX INC showed an increase of +281.9% in Operating Income Loss from 2024 to 2025.
- This data is from NOVAVAX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: -$9.47 million | Q3 2010: -$10.54 million | Q1 2011: -$7.43 million | Q2 2011: -$5.92 million | Q3 2011: -$3.97 million | Q1 2012: -$7.47 million | Q2 2012: -$5.86 million | Q3 2012: -$6.85 million | Q1 2013: -$10.01 million | Q2 2013: -$12.90 million | Q3 2013: -$15.28 million | Q1 2014: -$14.39 million | Q2 2014: -$17.85 million | Q3 2014: -$19.79 million | Q1 2015: -$24.31 million | Q2 2015: -$20.82 million | Q3 2015: -$33.20 million | Q1 2016: -$75.26 million | Q2 2016: -$76.50 million | Q3 2016: -$63.31 million | Q1 2017: -$40.83 million | Q2 2017: -$41.47 million | Q3 2017: -$41.63 million | Q1 2018: -$43.51 million | Q2 2018: -$41.99 million | Q3 2018: -$41.90 million | Q1 2019: -$40.22 million | Q2 2019: -$36.67 million | Q3 2019: -$14.99 million | Q1 2020: -$22.90 million | Q2 2020: -$17.03 million | Q3 2020: -$193.94 million | Q1 2021: -$208.63 million | Q2 2021: -$345.83 million | Q3 2021: -$307.14 million | Q1 2022: $209.29 million | Q2 2022: -$482.96 million | Q3 2022: -$127.19 million | Q1 2023: -$312.77 million | Q2 2023: $55.46 million | Q3 2023: -$125.63 million | Q1 2024: -$144.83 million | Q2 2024: $161.00 million | Q3 2024: -$134.02 million | Q1 2025: $515.51 million | Q2 2025: $101.07 million | Q3 2025: -$178.02 million.
- Over the full 17 years of available data (2009 to 2025), NOVAVAX INC's Operating Income Loss has grown by 1,311.2%.
- Historical annual values: Fiscal year 2025: $452.80 million | Fiscal year 2024: -$248.93 million | Fiscal year 2023: -$566.51 million | Fiscal year 2022: -$644.74 million | Fiscal year 2021: -$1.69 billion | Fiscal year 2020: -$416.72 million | Fiscal year 2019: -$120.58 million | Fiscal year 2018: -$173.92 million | Fiscal year 2017: -$171.71 million | Fiscal year 2016: -$269.11 million | Fiscal year 2015: -$157.24 million | Fiscal year 2014: -$83.69 million | Fiscal year 2013: -$52.43 million | Fiscal year 2012: -$29.67 million | Fiscal year 2011: -$21.58 million | Fiscal year 2010: -$38.49 million | Fiscal year 2009: -$37.38 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: